Abiopharma

🔍 Collier Charles (Executive)

Company: ROKU, INC (ROKU)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 10,269 shares of Class A Common Stock at $49.59 per share (Direct)
  Date: 2026-05-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,969.00 | transaction_form_type: 4
• Sold 2,521 shares of Class A Common Stock at $123.18 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,448.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 4,410 shares of Class A Common Stock at $123.98 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,038.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 3,235 shares of Class A Common Stock at $125.29 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,803.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 103 shares of Class A Common Stock at $125.91 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,700.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 10,269 shares of Class A Common Stock at $49.59 per share (Direct)
  Date: 2026-05-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,969.00 | transaction_form_type: 4
• Sold 2,375 shares of Class A Common Stock at $123.29 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,594.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 4,566 shares of Class A Common Stock at $124.0 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,028.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 3,208 shares of Class A Common Stock at $125.24 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,820.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 120 shares of Class A Common Stock at $125.94 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,700.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 10,269 shares of Employee Stock Option (right to buy) at $49.59 per share (Derivative)
  Date: 2026-05-04 | Code: M | Expires: 2032-11-03 | equity_swap_involved: 0 | shares_owned_after: 133,496.00 | transaction_form_type: 4 | Footnotes: F8
• Sold 10,269 shares of Employee Stock Option (right to buy) at $49.59 per share (Derivative)
  Date: 2026-05-04 | Code: M | Expires: 2032-11-03 | equity_swap_involved: 0 | shares_owned_after: 123,227.00 | transaction_form_type: 4 | Footnotes: F8

Footnotes:

• F1: Shares sold pursuant to Mr. Collier's 10b5-1 plan.
• F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.58 to $123.57 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.58 to $124.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.74 to $125.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.58 to $123.57 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.58 to $124.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.74 to $125.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F8: This stock option vests in 48 substantially equal monthly installments. The first installment vested on December 4, 2022.